All of Us Returns Health-Related DNA...
The National Institutes of Health’s All of Us Research Program has returned personalized health-related DNA results to more than...
This study is designed to investigate the safety and efficacy of Nab®-Paclitaxel (ABRAXANE®) in combination with Carboplatin as first line treatment.
Contact Candace LeBlanc 508-556-5431 or Marcy Kirkpatrick 508-556-5429 for more information.
For more information about this study:
https://clinicaltrials.gov/ct2/show/NCT02151149